✦ LIBER ✦

Is HER-2 over expression associated with brain metastases in Chinese breast cancer patients?

✍ Scribed by D. Suen; A. Lee; A. Kwong

Book ID: 119598221
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 73 KB
Volume: 6
Category: Article
ISSN: 1359-6349
DOI: 10.1016/s1359-6349(08)70729-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of brain metastases in patient

Treatment of brain metastases in patients with HER2+ breast cancer

✍ J. M. Bravo Marques 📂 Article 📅 2009 🏛 Springer Healthcare Communications 🌐 English ⚖ 648 KB

Occult brain metastases in her-2-positiv

Occult brain metastases in her-2-positive breast cancer patients

✍ A. Niwinska; Tacikowska; T. Pienkowski; I. Lemanska; B. Bauer; H. Rudnicka 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 136 KB

Brain metastases in HER-2 positive metas

Brain metastases in HER-2 positive metastatic breast cancer (MBC) patients

✍ R. Duchnowska; Czartoryska-Arlukowicz; B. Radecka; B. Szostakiewicz; A. Karpinsk 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 269 KB

Role of trastuzumab in patients with bra

Role of trastuzumab in patients with brain metastases from Her2 positive breast cancer

✍ Nilufer Bulut; Hakan Harputluoglu; Omer Dizdar; Kadri Altundag 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 84 KB

Trastuzumab prolongs overall survival in

Trastuzumab prolongs overall survival in patients with brain metastases from Her2 positive breast cancer

✍ Rupert Bartsch; Andrea Rottenfusser; Catharina Wenzel; Karin Dieckmann; Ursula P 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 162 KB

Survival in patients with brain metastas

Survival in patients with brain metastases from breast cancer : The importance of HER-2 status

✍ April F. Eichler; Irene Kuter; Paula Ryan; Lidia Schapira; Jerry Younger; John W 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 183 KB 👁 2 views

## Abstract ## BACKGROUND Brain metastases (BM) are the most common intracranial tumors in adults. To the authors' knowledge, established prognostic factors for survival after the diagnosis of BM in breast cancer patients do not take into account HER–2 status, which may have increasing relevance i